# Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy

> **NCT03173638** · PHASE2 · UNKNOWN · sponsor: **Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA** · enrollment: 5 (actual)

## Conditions studied

- Non Arteritic Ischemic Optic Neuropathy

## Interventions

- **PROCEDURE:** intravitreal injection of MSV

## Key facts

- **NCT ID:** NCT03173638
- **Lead sponsor:** Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-23
- **Primary completion:** 2022-04
- **Final completion:** 2022-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2021-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03173638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03173638, "Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03173638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*